Let’s look at this differently

This morning per a press release we learned;

“EOFLOW CO., Ltd., an emerging medical device manufacturer with offices in Seoul, South Korea and San Jose, California, announced today that its closed loop Automated Insulin Delivery /Artificial Pancreas Device (AID/AP), the EOPancreas System, has received Breakthrough Device Designation by the U.S. Food and Drug Administration.”

EOFLOW is just one of the many insulin pump wannabes seeking to enter the ever-crowded insulin pump market. Anyone who has seen the EOFLOW will notice that it remarkable looks a lot like the OmniPod from Insulet. Now we aren’t sure just . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.

This entry was posted in Email Alerts. Bookmark the permalink.